Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more
Image 3
Events 17/05/2022

Secerna to attend BIO International 2022

News218
Team news 10/05/2022

Secerna celebrates an international anniversary

News217
Events, News 05/05/2022

IP and Youth: Innovating for a Better Future on World IP Day 2022

News214
Industry news, News 02/05/2022

Intellectual Property Opportunities in Quantum Computing

News215
Events 25/04/2022

Secerna sponsor BioVale Pitchfest event

B012978
Team news, Careers 21/04/2022

George McCanney in profile

EU Flag UPC article
European, Industry news, UPC 18/04/2022

What businesses need to do to prepare for the upcoming Unitary Patent and the Unified Patent Court

EU Flag UPC article
European, UPC 07/04/2022

The new EU forum for patent disputes – the Unified Patent Court

Europe (1)
European, News 01/04/2022

Major developments for patents in Europe – the Unitary Patent

20 21 22 23 24 25 26 27 28 29 30